Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes
暂无分享,去创建一个
Matthew Bogyo | M. Bogyo | Margot G Paulick | G. Blum | Laura E Edgington | Galia Blum | Victoria E. Albrow | Alicia B Berger | Victoria E Albrow | Neil Lineberry | L. Edgington | N. Lineberry | A. B. Berger
[1] F. Blankenberg,et al. Radiolabeling of HYNIC–annexin V with technetium-99m for in vivo imaging of apoptosis , 2006, Nature Protocols.
[2] R. Mach,et al. Synthesis, radiolabeling, and in vivo evaluation of an 18F-labeled isatin analog for imaging caspase-3 activation in apoptosis. , 2006, Bioorganic & medicinal chemistry letters.
[3] J. Ellman,et al. Parallel solution-phase synthesis of mechanism-based cysteine protease inhibitors. , 2001, Organic letters.
[4] R. Weissleder,et al. Near-infrared fluorescent imaging of tumor apoptosis. , 2003, Cancer research.
[5] M. Bogyo,et al. Identification of early intermediates of caspase activation using selective inhibitors and activity-based probes. , 2006, Molecular cell.
[6] P. Doevendans,et al. Visualisation of cell death in vivo in patients with acute myocardial infarction , 2000, The Lancet.
[7] D. Lawrence,et al. Structural and functional analysis of the interaction between the agonistic monoclonal antibody Apomab and the proapoptotic receptor DR5 , 2008, Cell Death and Differentiation.
[8] G. Slegers,et al. Sequential 99mTc-hydrazinonicotinamide-annexin V imaging for predicting response to chemotherapy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] M. Bogyo,et al. Design of cell-permeable, fluorescent activity-based probes for the lysosomal cysteine protease asparaginyl endopeptidase (AEP)/legumain. , 2007, Bioorganic & medicinal chemistry letters.
[10] K. Zavitsanou,et al. Detection of apoptotic cell death in the thymus of dexamethasone treated rats using [123I]Annexin V and in situ oligonucleotide ligation , 2007, Journal of Molecular Histology.
[11] I. Ziv,et al. From the Gla domain to a novel small-molecule detector of apoptosis , 2009, Cell Research.
[12] I. Ziv,et al. Molecular imaging of cell death in vivo by a novel small molecule probe , 2006, Apoptosis.
[13] N. Thornberry,et al. A Combinatorial Approach Defines Specificities of Members of the Caspase Family and Granzyme B , 1997, The Journal of Biological Chemistry.
[14] B. Lebleu,et al. Cellular Uptake of Unconjugated TAT Peptide Involves Clathrin-dependent Endocytosis and Heparan Sulfate Receptors* , 2005, Journal of Biological Chemistry.
[15] M. Bogyo,et al. Specificity of aza-peptide electrophile activity-based probes of caspases , 2007, Cell Death and Differentiation.
[16] J. Ripoll,et al. Visualization of antitumor treatment by means of fluorescence molecular tomography with an annexin V-Cy5.5 conjugate. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Vandenabeele,et al. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity , 2003, Cell Death and Differentiation.
[18] N. Méthot,et al. A Caspase Active Site Probe Reveals High Fractional Inhibition Needed to Block DNA Fragmentation* , 2004, Journal of Biological Chemistry.
[19] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[20] Z. Darżynkiewicz,et al. Interactions of fluorochrome‐labeled caspase inhibitors with apoptotic cells: A caution in data interpretation , 2003, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[21] Vasilis Ntziachristos,et al. Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy. , 2003, Neoplasia.
[22] Z. Darżynkiewicz,et al. Activation of caspases measured in situ by binding of fluorochrome-labeled inhibitors of caspases (FLICA): correlation with DNA fragmentation. , 2000, Experimental cell research.
[23] Thomas L. Chenevert,et al. Noninvasive real-time imaging of apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] Z. Darżynkiewicz,et al. Detection of caspases activation by fluorochrome-labeled inhibitors: Multiparameter analysis by laser scanning cytometry. , 2001, Cytometry.
[25] U. Haberkorn,et al. 131I-labeled peptides as caspase substrates for apoptosis imaging. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] J. Brewer,et al. Thymocyte Apoptosis Induced by T Cell Activation Is Mediated by Glucocorticoids In Vivo1 , 2002, The Journal of Immunology.
[27] Cohen Jj. Glucocorticoid-induced apoptosis in the thymus. , 1992 .
[28] Roland Hustinx,et al. Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human Annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[29] A. Ashkenazi. Targeting the extrinsic apoptosis pathway in cancer. , 2008, Cytokine & growth factor reviews.
[30] J. Cohen. Glucocorticoid-induced apoptosis in the thymus. , 1992, Seminars in immunology.
[31] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[32] K. Bullok,et al. Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. , 2005, Journal of medicinal chemistry.
[33] Matthew Bogyo,et al. Activity-based probes that target diverse cysteine protease families , 2005, Nature chemical biology.
[34] G. Slegers,et al. 99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma , 2004, Nuclear medicine communications.
[35] T. Mizuochi,et al. Macrophages are involved in DNA degradation of apoptotic cells in murine thymus after administration of hydrocortisone , 2002, Cell Death and Differentiation.
[36] D. Felsher,et al. Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.